Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study

Background: Randomized clinical trials showed that maintenance chemotherapy plus biologics in patients with mCRC could increase the progression free survival (PFS) without any advantage for overall survival (OS). Our aim was to study the real-life experience (onco-colon registry Turkey) of maintenance chemotherapy with antiEGFR or antiVEGF mAbs after the standart firstline doublet chemotherapy backbone in RAS wild-type mCRC patients.

Keywords

Metastatic Colon Cancer (mCRC) , Chemotherapy , Onco-Colon Turkey Study

Journal or Series

Annals of Oncology

WoS Q Value

Q1

Volume

33

Issue

Supplement:4

Citation

Artaç, M., Çubukçu, E., Bozkurt, O., Bilici, A., Çelik, S., Özçelik, M. ... Gümüş, M. (2022). Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study. Annals of Oncology içinde (S281-S282. ss.). https://doi.org/10.1016/j.annonc.2022.04.182

URI

https://doi.org/10.1016/j.annonc.2022.04.182
https://hdl.handle.net/20.500.12511/9646

Collections

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu

Rights and licensing

info:eu-repo/semantics/embargoedAccess

Full item page

Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study

Files

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Access Rights

DOI

Abstract

Description

Keywords

Journal or Series

WoS Q Value

Scopus Q Value

Volume

Issue

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing